about
Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?Oxidative Stress and First-Line Antituberculosis Drug-Induced Hepatotoxicity.Vitamin C and Mycobacterium tuberculosis PersistersErratum for Yew et al., "Oxidative Stress and First-Line Antituberculosis Drug-Induced Hepatotoxicity"New drugs and regimens for tuberculosisManagement of adverse reactions to high-dose moxifloxacin used in multidrug-resistant tuberculosis treatment programmesCan vitamin C help in managing tuberculosis associated with diabetes mellitus?Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of pncA PCR Sequencing
P50
Q48362853-887B40A8-62E1-46A7-AF13-2131B9400B07Q54203690-547A1EA6-C70B-49C3-9AB0-4E1F3A24115BQ57789660-E1C656BF-2921-486E-A7B2-2F3DA5D69D61Q58701175-B38AF8AC-9693-44A2-B65A-775DBDFFE6C1Q89149728-CE09ECE2-C37D-469B-86DD-1853AFCD720AQ90300160-63EF5323-D700-40A2-98AB-EB3ADCD34EA0Q92151565-CA4A580F-D245-46CA-8E06-B47881FB8294Q92688924-B2FF34AB-2F52-4B8F-BA92-F966CF87B519
P50
description
researcher
@en
wetenschapper
@nl
name
Kwok Chiu Chang
@en
Kwok Chiu Chang
@nl
type
label
Kwok Chiu Chang
@en
Kwok Chiu Chang
@nl
prefLabel
Kwok Chiu Chang
@en
Kwok Chiu Chang
@nl
P31
P496
0000-0002-3682-5069